Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »Tesla file is unstoppable. Here’s what could go on.
Last week, two bearish analysts finally threw in the towel on Tesla, and the stock market has not stopped running. The stock hit another $ 381 this week, up 24%, expanding its 2020 earnings to around 380%. Shares broke the $ 2,000 barrier on Thursday and, of course, rose again …
Read More »A tidal wave of news about covid vaccine is on the market
Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »Potential Gilead blockbusters rejected by FDA. Why that’s the ‘Near-Worst-Case Scenario’ for Gilead Stock.
Text size The Food and Drug Administration on Tuesday rejected Gilead Science’s application for a will-be blockbuster arthritis medicine, blind investors. One analyst called the development a ‘near-worst-case scenario’ and a ‘shock’. Dreamstime The Food and Drug Administration’s decision to deny Gilead Science’s application for a wild medicine for blockbuster …
Read More »Sanofi Buys Principia for $ 3.7 billion. Both front runs.
Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …
Read More »